Jean Hoffman-Censits, MD
Medical Oncology · Baltimore, MDNPI 1245480607
Payments from drug & device makers
Across 382 payments — averaging $14,916 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$4.5M
- Daiichi Sankyo Inc.$270K
- Daiichi Sankyo Company LTD$269K
- Pfizer$180K
- Genentech, Inc.$165K
- Ares Trading SA$106K
- plus $215K from 8 others
Across 18 payments — averaging $1117.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$16K
- F. Hoffmann-la Roche AG$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 241 | $4,492,871 |
| Daiichi Sankyo Inc. | 10 | $270,390 |
| Daiichi Sankyo Company LTD | 10 | $268,526 |
| Pfizer | 21 | $180,359 |
| Genentech, Inc. | 10 | $165,355 |
| Ares Trading SA | 59 | $106,066 |
| QED Therapeutics, Inc. | 7 | $76,840 |
| Astellas Pharma Global Development | 4 | $61,977 |
| Novartis | 6 | $48,560 |
| EMD Serono Research & Development Institute, Inc. | 1 | $16,600 |
| F. Hoffmann-la Roche AG | 7 | $10,179 |
| EMD Serono, Inc. | 4 | $247 |
| E.r. Squibb & Sons, L.L.C. | 1 | $79 |
| AstraZeneca | 1 | $43 |
How this compares
$5,698,092 in reported general payments places this provider in the 95th percentile of 180 medical oncology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Baltimore
- Dung leBaltimore$18.7M
- Stephanie GaillardBaltimore$12.2M
- Ashraf BadrosBaltimore$7.2M
- Patrick BrownBaltimore$6.6M
- Nilofer AzadBaltimore$6.5M
- Ranee MehraBaltimore$5.2M
- Michael CarducciBaltimore$4.8M
- Tanguy Lim-SeiwertBaltimore$4.6M
- Mark LevisBaltimore$4.2M
- Arif HussainBaltimore$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.